Abstract
Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Current Pharmaceutical Design
Title: Cytokine Therapeutics for Infectious Diseases
Volume: 6 Issue: 6
Author(s): F. H. Rodriguez, S. Nelson and J. K. Kolls
Affiliation:
Keywords: adjuvants, Interferon Gamma, Chemokines, Colony stimulating factors, tumor necrosis, bronchoalvelar lavage fluid, granulocyte macrophage, human growth regulatory, alpha, Inflammatory protein, klebsiella pneumonia, Interleukin, sepsis, Pseudomonas aeruginosa, Mycobacterial infection
Abstract: Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines - growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
Export Options
About this article
Cite this article as:
Rodriguez H. F., Nelson S. and Kolls K. J., Cytokine Therapeutics for Infectious Diseases, Current Pharmaceutical Design 2000; 6 (6) . https://dx.doi.org/10.2174/1381612003400641
DOI https://dx.doi.org/10.2174/1381612003400641 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Flaxseed and Endotoxic Shock
Current Pharmaceutical Design Non-Alcoholic Fatty Liver Disease and Vascular Disease
Current Vascular Pharmacology Saponins as Tool for Improved Targeted Tumor Therapies
Current Drug Targets Arterial Thickness and Immunometabolism: The Mediating role of Chronic Exercise
Current Cardiology Reviews OPLS-DA as a Suitable Method for Selecting a Set of Gene Transcripts Discriminating RAS- and PTPN11-Mutated Cells in Acute Lymphoblastic Leukaemia
Combinatorial Chemistry & High Throughput Screening B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Current Aging Science Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine
Current Medicinal Chemistry Ethanol Withdrawal and Hyperalgesia
Current Drug Abuse Reviews Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Recent Patents on Biotechnology Update on Pathogenesis of Sjogren's Syndrome
Current Rheumatology Reviews Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors
Current Clinical Pharmacology Probiotics in Intestinal and Non-Intestinal Infectious Diseases – Clinical Evidence
Current Pharmaceutical Design Erythropoiesis Stimulating Agents and Techniques: A Challenge for Doping Analysts
Current Medicinal Chemistry Hsp70 in Oncology
Recent Patents on DNA & Gene Sequences The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
Current Neuropharmacology Recognition of Leishmania Parasites by Innate Immunity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Functionalized Organolithium Compounds: New Synthetic Adventures
Current Organic Chemistry